Keiichi Kinowaki

6PUBLICATIONS
6CO-AUTHORS
Medical biochemistry - lipidsCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
Primary hepatic pleomorphic liposarcoma with rupture.

|Jul 07, 2022
Complete response of metastatic renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus ipilimumab.

Michikata Hayashida, Yuji Miura, Taisho Noda

|Feb 17, 2022
TRIM39 is a poor prognostic factor for patients with estrogen receptor-positive breast cancer and promotes cell cycle progression.

Takuya Ogura, Kotaro Azuma, Toshihiko Takeiwa

|Nov 13, 2021
OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.

Takuya Ogura, Kotaro Azuma, Junichiro Sato

|Nov 10, 2021
Cystic partially differentiated nephroblastoma in a 74-year-old patient.

Michikata Hayashida, Shoichi Nagamoto, Akihiro Yano

|Nov 07, 2020
Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population.

Junichiro Sato, Kotaro Azuma, Keiichi Kinowaki

Pageof 1

Frequent Collaborators

3 joint publications

Satoshi Inoue

2 joint publications

Michikata Hayashida

1 joint publications

Masanobu Kitagawa

1 joint publications

Takuya Ogura